Our PAX7 score findings are different from previous studies as we did not detect significant overall reduction in PAX7 score in FSHD-affected biopsies compared to controls and the PAX7 score had limited strength as general biomarker for FSHD. The gene discussed is PAX7; the disease is Facioscapulohumeral dystrophy.